White House Schedules Meeting On Cannabis Products Enforcement Policy For Next Week
The White House has scheduled a meeting on cannabis products enforcement policy, signaling potential federal regulatory changes. This policy directly affects patient access to cannabis medications and clinical practice. Healthcare providers should…
The CBD Conversation – Insights for Chiropractic Economics
Chiropractors increasingly face CBD clinical practice challenges as patients use CBD for pain management. This article highlights the need for evidence-based frameworks in CBD clinical practice. Optimizing patient outcomes requires informed CBD clinical…
Why RFK Jr.’s firing of FDA experts likely won’t improve public trust
FDA regulation policy clinical practice is crucial for cannabis medicine oversight and patient safety. Recent leadership changes at the FDA raise concerns about regulatory consistency. Clinicians must focus on evidence-based practices amid evolving…
Congress Should Stop Scheduling Substances Without Consulting the Science
Legislative scheduling decisions cannabis create barriers to evidence-based medicine by bypassing scientific review. This limits physicians' ability to recommend appropriate treatments and restricts research. Reforming federal cannabis scheduling is…
Vikramm Mitra’s LinkedIn Post on Cannabis Clinical Relevance
This post highlights cannabis news clinical relevance with notable emerging findings. Healthcare professionals should monitor these developments closely. The content emphasizes the importance of evidence-based clinical practice.
US Cannabis Growth: Forecasting $30.5 Billion Legal Revenues by 2026
The US cannabis market expansion 2026 is forecasted to reach $30.5 billion in legal revenues, signaling significant industry growth. This expansion increases patient access to regulated cannabis products, impacting clinical practice. Clinicians should…
Emerging Insights: New Cannabis Research Findings Challenge Major Beliefs
New cannabis research findings are challenging long-held beliefs in the field. These emerging insights hold notable clinical relevance for healthcare providers. Understanding these findings is essential for informed patient care decisions.
Scathing Audit for Alabama Medical Marijuana Authority on Eve of Market Launch
The Alabama medical marijuana audit highlights significant regulatory failures affecting patient access and product safety. This audit raises concerns about the oversight of the state's medical cannabis program. Healthcare providers and patients should…
Cannabis Dispensary Staff (“Budtender”) Perspectives on Trustworthiness of Social Media Information: A Qualitative Study.
Cannabis dispensary staff perspectives reveal skepticism toward social media as a reliable source for cannabis information. Budtenders prioritize experiential knowledge over online content. This study highlights challenges in cannabis information quality…
Canadian Conservative Leader Supports Cannabis as a Personal Choice
Political shifts cannabis acceptance are reshaping medical cannabis access and regulatory frameworks. A Canadian Conservative leader's support signals evolving cannabis policy reform. Clinicians should monitor these changes for future clinical practice…